Anemia Research Today is a free monthly online journal that collates and summarizes the latest research about Anemia, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 2 (2005), Issue 8 (August)

1. Nucleotide -88 (C-T) promoter mutation is a common beta-thalassemia mutation in the Jat Sikhs of Punjab, India.
   Am J Hematol, 79(4): 252-6. [Abstract] [Full-text]
2. Clonal T cells of pure red-cell aplasia.
   Am J Hematol, 79(4): 332-3. [Abstract] [Full-text]
3. Bone mineral density in children with thalassaemia major: determining factors and effects of bone marrow transplantation.
   Bone Marrow Transplant, 36(4): 331-6. [Abstract] [Full-text]
4. Transplantation of CD34+ selected peripheral blood to HLA-identical sibling patients with aplastic anaemia: results from a single institution.
   Bone Marrow Transplant, 36(4): 325-9. [Abstract] [Full-text]
5. The anaemia of cancer: death by a thousand cuts.
   Nat Rev Cancer, 5(7): 543-55. [Abstract] [Full-text]
6. Anaesthesia for peculiar cells--a century of sickle cell disease.
   Br J Anaesth, 95(3): 287-99. [Abstract] [Full-text]
7. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients.
   Blood, 106(4): 1460-5. [Abstract] [Full-text]
8. Identification of 2 major loci linked to autoimmune hemolytic anemia in NZB mice.
   Blood, 106(4): 1323-9. [Abstract] [Full-text]
9. Evidence for a protective role of the Gardos channel against hemolysis in murine spherocytosis.
   Blood, 106(4): 1454-9. [Abstract] [Full-text]
10. Multidimensional assessment using the adolescent pediatric pain tool: a case report.
    J Spec Pediatr Nurs, 10(3): 115-23. [Abstract] [Full-text]
11. A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease.
    Int J Behav Med, 12(3): 171-9. [Abstract] [Full-text]
12. Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature.
    Z Gastroenterol, 43(8): 719-22. [Abstract] [Full-text]
13. Once-weekly treatment of anemia in patients with cancer: a comparative review of epoetins.
    Oncology, 68(2): 122-9. [Abstract] [Full-text]
14. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes.
    J Clin Endocrinol Metab, 90(8): 4446-51. [Abstract] [Full-text]
15. Pancytopenia in children: etiological profile.
    J Trop Pediatr, 51(4): 236-9. [Abstract] [Full-text]
16. Clinical evaluation of extract of Cajanus cajan (Ciklavit) in sickle cell anaemia.
    J Trop Pediatr, 51(4): 200-5. [Abstract] [Full-text]
17. Development of a clinical prediction rule for iron deficiency anemia in pregnancy.
    Am J Obstet Gynecol, 193(2): 460-6. [Abstract] [Full-text]
18. Relation of anemia at discharge to survival after acute coronary syndromes.
    Am J Cardiol, 96(4): 496-9. [Abstract] [Full-text]
19. Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection.
    Br J Haematol, 130(4): 644-6. [Abstract] [Full-text]
20. Clinical and molecular variability in congenital dyserythropoietic anaemia type I.
    Br J Haematol, 130(4): 628-34. [Abstract] [Full-text]
21. Guidelines on anaemia: effect on primary-care midwives in The Netherlands.
    Midwifery, 21(3): 204-11. [Abstract] [Full-text]
22. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1.
    Acta Haematol, 114(2): 113-6. [Abstract] [Full-text]
23. Reticulocyte changes after experimental anemia and erythropoietin treatment of horses.
    J Appl Physiol, 99(3): 915-21. [Abstract] [Full-text]
24. Fecundity and pregnancy outcome in a cohort with sickle cell-haemoglobin C disease followed from birth.
    BJOG, 112(9): 1308-14. [Abstract] [Full-text]
25. Glycemic monitoring in diabetics with sickle cell plus beta-thalassemia hemoglobinopathy.
    Ann Pharmacother, 39(9): 1557-60. [Abstract] [Full-text]
26. Hypersensitivity syndrome and pure red cell aplasia following allopurinol therapy in a patient with chronic kidney disease.
    Ann Pharmacother, 39(9): 1552-6. [Abstract] [Full-text]
27. Red blood cell lactate transport in sickle disease and sickle cell trait.
    J Appl Physiol, 99(3): 822-7. [Abstract] [Full-text]
28. A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major.
    Eur J Haematol, 75(3): 241-7. [Abstract] [Full-text]
29. Anemia, tumor hypoxemia, and the cancer patient.
    Int J Radiat Oncol Biol Phys, 63(1): 25-36. [Abstract] [Full-text]
30. Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
    Leuk Res, 29(10): 1213-5. [Abstract] [Full-text]
31. The management of anemia in the myelodysplastic syndrome.
    Leuk Res, 29(10): 1101-2. [Abstract] [Full-text]
32. A dinucleotide deletion in the ankyrin promoter alters gene expression, transcription initiation and TFIID complex formation in hereditary spherocytosis.
    Hum Mol Genet, 14(17): 2501-9. [Abstract] [Full-text]
33. Disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following Rh(0)(D) immune globulin intravenous administration for immune thrombocytopenic purpura.
    Blood, 106(5): 1532-7. [Abstract] [Full-text]
34. Life-threatening nonspherocytic hemolytic anemia in a patient with a null mutation in the PKLR gene and no compensatory PKM gene expression.
    Blood, 106(5): 1851-6. [Abstract] [Full-text]
35. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
    Br J Haematol, 130(5): 747-51. [Abstract] [Full-text]
36. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content.
    JAMA, 294(8): 924-30. [Abstract] [Full-text]
37. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
    J Pediatr, 147(2): 244-7. [Abstract] [Full-text]
38. Non-skewed X-inactivation may cause mental retardation in a female carrier of X-linked alpha-thalassemia/mental retardation syndrome (ATR-X): X-inactivation study of nine female carriers of ATR-X.
    Am J Med Genet A, 138(1): 18-20. [Abstract] [Full-text]
39. The natural history of severe anemia in cartilage-hair hypoplasia.
    Am J Med Genet A, 138(1): 35-40. [Abstract] [Full-text]
40. Defective binding of transcriptional repressor ZEB via DNA methylation contributes to increased constitutive levels of p73 in Fanconi anemia cells.
    FEBS Lett, 579(21): 4610-4. [Abstract] [Full-text]
41. Epoetin alfa use in patients with ESRD: an analysis of recent US prescribing patterns and hemoglobin outcomes.
    Am J Kidney Dis, 46(3): 481-8. [Abstract] [Full-text]
42. Proteinuria and hemoglobin levels in patients with primary glomerular disease.
    Am J Kidney Dis, 46(3): 424-31. [Abstract] [Full-text]
43. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.
    Nat Genet, 37(9): 931-3. [Abstract] [Full-text]
44. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.
    Nat Genet, 37(9): 934-5. [Abstract] [Full-text]
45. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M.
    Nat Genet, 37(9): 958-63. [Abstract] [Full-text]
46. The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair.
    Nat Genet, 37(9): 953-7. [Abstract] [Full-text]

© 2004-2010 Anemia Research Today. All Rights Reserved.